MICHAEL J BAUM

Allopathic & Osteopathic Physicians|Family Medicine SOUTH PLAINFIELD, NJ NPI 1376694786

General Payments — all program years on this page

$1,320.74

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 72
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $244.46 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $244.4616

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Exact Sciences Corporation $61.144
GlaxoSmithKline, LLC. $57.964
Lilly USA, LLC $43.673
Novo Nordisk AS $30.162
Acerta Pharma LLC $27.082
Abbott Laboratories $24.451

By program year

Program yearAmountRecords
2018 $250.9217
2019 $233.5217
2020 $159.0212
2021 $220.071
2022 $212.759
2023 $244.4616

Records — PY2023 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1000196813 Novo Nordisk Inc $15.05 10/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1000196821 Novo Nordisk Inc $15.11 03/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003534075 GlaxoSmithKline, LLC. $14.60 06/08/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003534409 GlaxoSmithKline, LLC. $15.12 09/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003534415 GlaxoSmithKline, LLC. $13.32 10/27/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003534617 GlaxoSmithKline, LLC. $14.92 10/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011689187 AstraZeneca Pharmaceuticals LP $12.91 04/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011963037 AstraZeneca Pharmaceuticals LP $14.17 09/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1018482037 Abbott Laboratories $24.45 04/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1026570799 Exact Sciences Corporation $16.19 02/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1026570869 Exact Sciences Corporation $13.57 04/27/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1026570929 Exact Sciences Corporation $16.26 06/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1026570991 Exact Sciences Corporation $15.12 09/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031844585 Lilly USA, LLC $14.22 04/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031918069 Lilly USA, LLC $15.36 02/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032060485 Lilly USA, LLC $14.09 03/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.